Navigation Links
Genta Incorporated Announces Third Quarter 2007 Financial Results
Date:11/7/2007

y recruiting patients for a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed an oral formulation of the active ingredient in Ganite that is currently undergoing initial clinical trials as a potential treatment for diseases associated with accelerated bone loss. Ganite(R) and Genasense(R) are available on a "named-patient" basis in countries outside the United States. For more information about Genta, please visit our website at: http://www.genta.com.

Safe Harbor

This press release may contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward- looking statements include, without limitation, statements about:

-- the Company's ability to obtain necessary regulatory approval for

Genasense(R) from the U.S. Food and Drug Administration ("FDA") or

European Medicines Agency ("EMEA");

-- the safety and efficacy of the Company's products or product

candidates;

-- the Company's assessment of its clinical trials;

-- the commencement and completion of clinical trials;

-- the Company's ability to develop, manufacture, license and sell its

products or product candidates;

-- the Company's ability to enter into and successfully execute license

and collaborative agreements, if any;

-- the adequacy of the Company's capital resources and cash flow

projections, and the Company's ability to obtain sufficient financing

<
'/>"/>
SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013  B. Braun Medical ... and environmental safety with products, services and education ... feature its innovative Outlook® 400ES and Space Infusion ... capabilities at the American Association of Critical-Care Nurses ... Boston Convention Center. ...
(Date:5/20/2013)... 20, 2013 /PRNewswire-iReach/ -- It is no secret that Americans ... overweight or obese gyms and supplement companies are in line ... is primarily related to dietary issues and a lack of ... of a glandular problem or even a vitamin deficiency. ... deficiency is a lack of vitamin b12 . The ...
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Today at American Society for ... Ginocchio discussed Specific Technologies blood culture ... of microorganisms producing bloodstream infection. Dr. Ginocchio is ... Division of Infectious Disease Diagnostics at North Shore-LIJ ... health system. (Photo: http://photos.prnewswire.com/prnh/20130520/CG16829 ) ...
Breaking Medicine Technology:B. Braun Committed To Improving Patient Safety 2USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 2Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio 3
... U.S. Food and Drug Administration today announced steps to ... devices that can lead to the transmission of disease. ... Medical devices intended for repeated use are commonplace ... durable substances that can withstand reprocessing, a multistep process ...
... (NASDAQ: KOOL ), a leading supplier of innovative ... will report financial results for the fiscal third quarter ended March ... Company,s Conference Call and Webcast Management ... PM Pacific (5:00 PM Eastern) to review the fiscal third quarter ...
Cached Medicine Technology:FDA Looks to Improve Design and Cleaning Instructions for Reusable Medical Devices 2FDA Looks to Improve Design and Cleaning Instructions for Reusable Medical Devices 3ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011 2
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 According to ... Cancer Warnings at Indoor Tanning Salons,” tanning salons ... regulations. The Food and Drug Administration wants to see cancer ... of a minimum age floor of eighteen for the use ... to concerns about melanoma, which has become increasingly common over ...
(Date:5/20/2013)... The Environmental Design Research Association ... continuing education credit opportunities for design professionals, including ... Continuing Education System (AIA/CES), the Landscape Architecture Continuing ... Continuing Education Council (IDCEC). EDRA44Providence takes ... the Omni Providence Hotel in Providence, Rhode Island. ...
(Date:5/20/2013)... Co-founder of Atlanta SEO company EverSpark Interactive, ... 5th International INVEST Domaining & Internet Marketing Conference in ... and independent individuals from around the world to discuss ... The 2013 conference will take place at the Mexico ... to 21. A networking city tour day is on ...
(Date:5/20/2013)... The judge overseeing pretrial proceedings in the ... for female lawyers to be included in a plaintiffs’ ... LLP acknowledges the judge’s request, noting that its ... information on Mirena side effects and how to file ... addition of some female lawyers to the committee. This ...
(Date:5/20/2013)... of Texas Medical Branch at Galveston researchers have been ... Institute of Neurological Disorders and Stroke to apply the ... pain that is, pain that arises from a ... is a daily reality for millions of Americans, manifesting ... from neuropathic pain might feel intense discomfort in response ...
Breaking Medicine News(10 mins):Health News:Tanning - FDA Wants Tanning Salons to Post Cancer Warning Signs 2Health News:Environmental Design Research Conference to Feature AIA/CES, LA CES, and IDCEC Continuing Education Credits 2Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2Health News:Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP 2Health News:Pain, pain, go away 2Health News:Pain, pain, go away 3
... ... and other mobility solutions through their online store. , ... Raleigh, NC (PRWEB) September 18, 2009 -- The grand opening of 4 Stair Lifts ... ,Gerry Graham explained, "We know just how important household access is for those with limited mobility. ...
... , LISLE, IL, Sept. 17 /PRNewswire-FirstCall/ - SXC Health Solutions ... TSX: SXC) announced today the pricing of its previously announced ... sell 4,500,000 common shares at a price to the public ... previously announced offering size of 3,500,000 common shares. In connection ...
... , , CONCORD, N.C., Sept. 17 ... just an all American kid driving an all American hot rod. ... reflect that statement. , , (Photo: ... voting and more than 300 designs submitted, Liam Flanagan, an eight-year-old resident ...
... of life, study finds, , THURSDAY, Sept. 17 (HealthDay News) ... as smoking, high blood pressure and high cholesterol are taking ... without these troubles, British researchers say. , Although death from ... control of cardiovascular risk factors and better care, this is ...
... , WASHINGTON, Sept. 17 Statement ... for Legal Reform, on the Obama Administration,s announcement of state ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080919/USCHAMBERLOGO ... encouraged that the Obama Administration has made medical liability reform ...
... , , MINNEAPOLIS, Sept. 17 ... leading provider of integrated employee health and productivity management solutions, announced ... Canaccord Adams Healthy Living Conference on Wednesday, September 23, 2009 at ... Boston Waterfront Hotel in Boston, MA. , , ...
Cached Medicine News:Health News:4 Stair Lifts Announces Grand Opening of Online Store 2Health News:SXC Health Solutions announces pricing of upsized public offering of common shares 2Health News:SXC Health Solutions announces pricing of upsized public offering of common shares 3Health News:SXC Health Solutions announces pricing of upsized public offering of common shares 4Health News:SXC Health Solutions announces pricing of upsized public offering of common shares 5Health News:Eight-Year-Old's 'All American' Paint Scheme Walks Away With Ford Customer Service Division's Funny Car Design Contest to Support Juvenile Diabetes Research Foundation 2Health News:Eight-Year-Old's 'All American' Paint Scheme Walks Away With Ford Customer Service Division's Funny Car Design Contest to Support Juvenile Diabetes Research Foundation 3Health News:Eight-Year-Old's 'All American' Paint Scheme Walks Away With Ford Customer Service Division's Funny Car Design Contest to Support Juvenile Diabetes Research Foundation 4Health News:Middle-Age Heart Risk Factors Shorten Men's Lives 2Health News:Middle-Age Heart Risk Factors Shorten Men's Lives 3Health News:HealthFitness to Present at the Canaccord Adams Healthy Living Conference 2
... high performance ultrasound design provides unique ... Echocardiography imaging requires superior spatial resolution, ... performance. The Terason Echo Ultrasound System, ... delivers a compact imaging platform without ...
... When myocardial infarction is suspected, ... sensitive rapid assay allows rapid ... troponin T from a single ... result is available within minutes ...
... Endoscopic cases it is extremely popular to combine ... Light. This combination affords the surgeon optimal ... an uncomfortable pose. The Dual Light System ... System. As such the light can be ...
... This configuration offers all the performance of ... priced perfectly for use in Outpatient Settings, Minor ... Mounting two single lights either side of ... set-up in a General OR when combining Flat ...
Medicine Products: